Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Caitlin E. Cox

November 21, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Yael L. Maxwell

November 16, 2019

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

L.A. McKeown

November 14, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

Presentation TCT 2019

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Presenter: Kenneth Ouriel

September 28, 2019

Advertisement

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Future Pulmonary Embolism Interventions: Wild West or Working Together?

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content